| AIF | Apoptosis-inducing factor |
| aSMase | Acid sphingomyelinase |
| ATF6 | Activating transcription factor 6 |
| ATP | Adenosine triphosphate |
| BER | Base excision repair |
| CDDP | Cisplatin |
| CHOP | C/EMP homologous protein |
| CP | Carboplatin |
| CRT | Calreticulin |
| CTR1 | High affinity copper uptake protein 1 |
| Cyt C | Cytochrome C |
| DAMP | Damage-associated molecular patterns |
| DC | Dendritic cell |
| DISC | Death-inducing signalling complex |
| DSB | Double strand breaks |
| ER | Endoplasmic reticulum |
| ERCC1 | Cross-complementation group 1 |
| FasR | Fas receptor |
| FDA | US Food and Drug Administration |
| FOLFOX | 5-fluorouracil, leucovorin, oxaliplatin drug combination |
| GEMOX | Gemcitabine, oxaliplatin drug combination |
| GSH | Glutathione |
| HCC | Hepatocellular carcinoma |
| HMGB1 | High-mobility group box 1 |
| HR | Homologous recombination |
| HSOS | Hepatic sinusoidal obstruction syndrome |
| IAP | Inhibitors of apoptosis proteins |
| ICD | Immunogenic cell death |
| ICL | Interstrand crosslink |
| IRE1α | Inositol-requiring protein 1α |
| IROX | Irinotecan, oxaliplatin drug combination |
| miRNA | microRNA |
| MMR | Mismatch repair |
| MRP | Multidrug resistance proteins |
| mtDNA | Mitochondrial DNA |
| nDNA | Nuclear DNA |
| NPM1 | Nucleophosmin |
| Nrf2 | NF-E2-related factor 2 |
| OCT | Organic cation transporter |
| OIPN | Oxaliplatin-induced peripheral neuropathy |
| OXP | Oxaliplatin |
| pEIF2α | Phosphorylated eukaryotic translation factor 2α |
| PERK | Protein kinase RNA-like endoplasmic reticulum kinase |
| Pol I | RNA Polymerase I |
| Pt | Platinum |
| Pt | Platinum |
| ROS | Reactive oxygen species |
| rRNA | Ribosomal RNA |
| ssDNA | Single strand DNA breaks |
| SSRP1 | structure specific recognition protein 1 |
| TFIIH | Transcription factor II H |
| TLR4 | Toll-like receptor 4 |
| UBF | Upstream binding factor |
| XPC | Xeroderma pigmentosum |